ADAM10 expression in gastric adenocarcinoma: Results of a curative gastrectomy cohort


Alakus H., Kaya M., ÖZER H., EĞİLMEZ H. R. , KARADAYI K.

PAKISTAN JOURNAL OF MEDICAL SCIENCES, vol.37, no.2, pp.543-549, 2021 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.12669/pjms.37.2.3613
  • Journal Name: PAKISTAN JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded, Scopus, Academic Search Premier, CAB Abstracts, EMBASE, Veterinary Science Database, Directory of Open Access Journals
  • Page Numbers: pp.543-549

Abstract

Objective: Gastric cancer is among the most common human cancers with high mortality rates. ADAM10, a member of the ADAM (a disintegrin and metalloproteinase) family has also been found to be associated with gastric carcinoma and has been suggested as a potential therapeutic target. Here, we investigated the association of ADAM10 expression with prognosis in gastric adenocarcinoma patients that underwent gastric resection with D2 lymph node dissection.